These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
475 related items for PubMed ID: 15295041
1. The antibiotic pipeline--challenges, costs, and values. Wenzel RP. N Engl J Med; 2004 Aug 05; 351(6):523-6. PubMed ID: 15295041 [No Abstract] [Full Text] [Related]
2. Antibiotic development: a victim of market forces? Tillotson GS. IDrugs; 2008 May 05; 11(5):340-6. PubMed ID: 18465675 [Abstract] [Full Text] [Related]
3. In search of sustainability: process R&D in light of current pharmaceutical industry challenges. Federsel HJ. Drug Discov Today; 2006 Nov 05; 11(21-22):966-74. PubMed ID: 17055405 [Abstract] [Full Text] [Related]
4. Drug companies snub antibiotics as pipeline threatens to run dry. Clarke T. Nature; 2003 Sep 18; 425(6955):225. PubMed ID: 13679874 [No Abstract] [Full Text] [Related]
5. Opinion: anticipating change in drug development: the emerging era of translational medicine and therapeutics. Fitzgerald GA. Nat Rev Drug Discov; 2005 Oct 18; 4(10):815-8. PubMed ID: 16224453 [Abstract] [Full Text] [Related]
6. [Glaxo Laboratories: 20 years of antibiotic therapy. The antibiotic, the germ and the patient]. Alibert JP. Rev Laryngol Otol Rhinol (Bord); 1988 Oct 18; 109(2):195-7. PubMed ID: 3043606 [No Abstract] [Full Text] [Related]
7. Drug discovery alliances. Jones A, Clifford L. Nat Rev Drug Discov; 2005 Oct 18; 4(10):807-8. PubMed ID: 16237845 [No Abstract] [Full Text] [Related]
8. Antibacterial research and development in the 21(st) Century--an industry perspective of the challenges. Thomson CJ, Power E, Ruebsamen-Waigmann H, Labischinski H. Curr Opin Microbiol; 2004 Oct 18; 7(5):445-50. PubMed ID: 15451498 [Abstract] [Full Text] [Related]
9. [The birth of the greatest invention of the 20th century]. Sevillano D, Ramos C. Rev Esp Quimioter; 2007 Sep 18; 20(3):354-8. PubMed ID: 18080034 [No Abstract] [Full Text] [Related]
10. The antibacterial drugs market. Kresse H, Belsey MJ, Rovini H. Nat Rev Drug Discov; 2007 Jan 18; 6(1):19-20. PubMed ID: 17269159 [No Abstract] [Full Text] [Related]
11. The demise of the blockbuster? Cutler DM. N Engl J Med; 2007 Mar 29; 356(13):1292-3. PubMed ID: 17392299 [No Abstract] [Full Text] [Related]
12. The urgent need for new antibacterial agents. Wise R, BSAC Working Party on The Urgent Need: Regenerating Antibacterial Drug Discovery and Development. J Antimicrob Chemother; 2011 Sep 29; 66(9):1939-40. PubMed ID: 21700627 [No Abstract] [Full Text] [Related]
13. The role of medicinal chemists in drug discovery. Greenlee WJ, Desai MC. Curr Opin Drug Discov Devel; 2005 Jul 29; 8(4):419-20. PubMed ID: 16022177 [No Abstract] [Full Text] [Related]
14. Antibiotics: a shot in the arm. Leeb M. Nature; 2004 Oct 21; 431(7011):892-3. PubMed ID: 15496888 [No Abstract] [Full Text] [Related]
15. Repairing the broken market for antibiotic innovation. Outterson K, Powers JH, Daniel GW, McClellan MB. Health Aff (Millwood); 2015 Feb 21; 34(2):277-85. PubMed ID: 25646108 [Abstract] [Full Text] [Related]
16. Conducting pharmaceutical R&D in India - Critical components of entry strategies. Gulati R. IDrugs; 2008 Nov 21; 11(11):817-22. PubMed ID: 18988126 [Abstract] [Full Text] [Related]
17. Drug life-cycle technologies. Fleming E, Ma P. Nat Rev Drug Discov; 2002 Oct 21; 1(10):751-2. PubMed ID: 12360253 [No Abstract] [Full Text] [Related]
18. [Antibiotics - quo vadit?]. Lode HM, Stahlmann R. Dtsch Med Wochenschr; 2012 Jun 21; 137(24):1314-6. PubMed ID: 22669701 [No Abstract] [Full Text] [Related]
19. Gaining medical momentum. Blake D. Nature; 2004 Jun 03; 429(6991 Suppl):19-23. PubMed ID: 15175707 [No Abstract] [Full Text] [Related]
20. What's fueling the biotech engine? Aggarwal S. Nat Biotechnol; 2007 Oct 03; 25(10):1097-104. PubMed ID: 17921989 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]